Dopamine turnover and metabolism in the striatum of parkinsonian rats grafted with genetically-modified human astrocytes

Neuroscience

Volumn 85, Issue 2, 1998, Pages 405-413

  Fitoussi, N ^a   Sotnik Barkai, I ^a   Tornatore, C ^b   Herzberg, U ^b   Yadid, G ^a  

^a BAR ILAN UNIVERSITY   (Israel)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Astrocytes; Catechol metabolites; Extracellular fluid; Genetic engineering; Microdialysis; Parkinson's disease

Indexed keywords

3 O METHYLDOPAMINE; 5 HYDROXYINDOLEACETIC ACID; 5 HYDROXYTRYPTOPHAN; AMINO ACID DECARBOXYLASE; CATECHOL METHYLTRANSFERASE; DIHYDROXYPHENYLACETIC ACID; DOPA; DOPAMINE; HOMOVANILLIC ACID; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL TRANSPLANTATION; CIRCLING BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; GENETIC ENGINEERING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOHISTOCHEMISTRY; MALE; MICRODIALYSIS; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

ANIMALS; ASTROCYTES; CELL LINE; CORPUS STRIATUM; DOPAMINE; GENE THERAPY; HUMANS; LEVODOPA; MALE; MICRODIALYSIS; PARKINSON DISEASE, SECONDARY; RATS; RATS, SPRAGUE-DAWLEY; TRANSFECTION; TRANSGENES; TRANSPLANTS; TYROSINE 3-MONOOXYGENASE;

EID: 0032495808     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(97)00635-0     Document Type: Article

References (35)

1. Abercrombie E. D., Bonatz A. E., Zigmond M. J. Effects of L-DOPA on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats. Brain Res. 525:1990;36-44.
2. Dluzen D., Reddy A., McDermott J. The aromatic amino acid decarboxylase inhibitor, NSD-1015, increases release of dopamine: response characteristics. Neuropharmacology. 31(12):1992;1223-1229.
3. Duvoisin R. C., Mytilineou C. Where is L-DOPA decarboxylated in the striatum after 6-hydroxydopamine nigrotomy? Brain Res. 152:1978;173-369.
4. Dyke L. Effect of decarboxylase inhibitors on brain p-tyrosin levels. Biochem. Pharmac. 36:1987;1373-1376.
5. Fisher L. J., Jinnah H. A., Kale L. C., Higgins G. A., Gage F. H. Survival and function of intrastriatally grafted primary fibroblasts genetically modified to produce L-DOPA. Neuron. 6:1991;371-380.
6. Freed W. J. Neural transplantation: prospects for clinical use. Cell Transplant. 2:1993;13-31.
7. Gage F. H., Fisher L. J., Jinnah H. A., Rosenberg M. B., Tuszynski M. H., Friedman T. Grafting genetically modified cells to the brain: conceptual and technical issues. Prog. Brain Res. 82:1990;1-10.
8. Glick S. D., Raucci J., Wang S., Keller R. W. Jr., Carlson J. N. Neurochemical predisposition to self-administer cocaine in rats: individual differences in dopamine and its metabolites. Brain Res. 653:1994;148-154.
9. Goldberg W. J., Bernstein J. J. Fetal cortical astrocytes migrate from cortical homografts throughout the host brain and over the glia limitans. J. Neurosci. Res. 20:1988;38-45.
10. Goldstein D. S., Zimlichman R., Stull R., Folio J., Levinson P. D., Keiser H. R., Kopin I. J. Measurement of regional neuronal removal of norepinephrine in man. J. clin. Invest. 76:1985;15-21.
11. Horellou P., Marlier L., Privat A., Mallet J. Behavioral effect of engineered cells that synthesize L-DOPA or dopamine after grafting into the rat neostriatum. Eur. J. Neurosci. 2:1990;116-119.
12. Hunter L. W., Rorie D. K., Tyce G. M. Inhibition of aromatic L-amino acid decarboxylase under physiological conditions: optimization of 3-hydroxybenzyldrazine concentration to prevent concurrent inhibition of monoamine oxidase. Biochem. Pharmac. 45(6):1993;1363-1366.
13. Johansen P. A., Wolf W. A., Kuhn D. M. Inhibition of tryptophan hydroxylase by benserazide and other catechols. Biochem. Pharmac. 41(4):1991;625-628.
14. Juorio A. V., Li X. M., Waltz W., Paterson I. A. Decarboxylation of L-DOPA by cultured mouse astrocytes. Brain Res. 626:1993;306-309.
15. Juorio A. V., Walz W., Sloley B. D. Absence of decarboxylation of some aromatic-L-amino acids by cultured astrocytes. Brain Res. 426:1987;183-186.
16. Kaplan G. P., Hartman B. K., Creveling C. R. Immunohistochemical demonstration of catechol-O- methyltransferase in mammalian brain. Brain Res. 167:1979;241-250.
17. La Gamma E. F., Weisinger G., Lenn N. J., Strecker R. E. Genetically modified primary astrocytes as cellular vehicles for gene therapy in the brain. Cell Transplant. 2:1993;207-214.
18. Li X. M., Juorio A. V., Waltz W., Paterson I. A., Walz W., Zhu M. Y., Boulton A. A. Gene expression of aromatic-L-amino decarboxylase in cultured rat glial cells. J. Neurochem. 59:1992;1172-1175.
19. Lundberg C., Horellou P., Mallet J., Bjorklund A. Generation of DOPA-producing astrocytes by retroviral transduction of the human tyrosine hydroxylase gene: in vitro characterization and in vivo effects in the rat Parkinson model. Expl Neurol. 139:1996;39-53.
20. Melamed E., Dafni N. Effect of electrical stimulation of nigrostriatal dopaminergic neurons on utilization of exogenous L-DOPA in rat corpus striatum. J. Pharm. Pharmac. 34:1982;820-822.
21. Melamed E., Globus M., Uzzan A., Rosenthal J. Is dopamine formed from exogenous L-DOPA stored within vesicles in striatal dopaminergic nerve terminals: implication for L-DOPAs mechanism of action in Parkinson's disease. Neurology. 35(Suppl.):1985;118.
22. Nissbrandt H., Engberg G., Wikstrom H., Magnusson T., Carlsson A. NDS-1034: an amino acid decarboxylase inhibitor with stimulatory action on dopamine synthesis not mediated by classical dopamine receptors. Naunyn-Schmiedeberg's Arch Pharmac. 338:1988;148-161.
23. Palmer T. D., Rosman G. J., Osborne W. R., Miller A. D. Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes. Proc. natn. Acad. Sci. U.S.A. 88:1991;1330-13324.
24. Paxinos G. and Watson C. (1986) The Rat in Stereotaxic Coordinates. Academic, Orlando, FL.
25. Perese D. A., Ulman J., Viola J., Ewing S. E., Bankiewicz K. S. A 6-hydroxydopamine-induced selective parkinsonian rat model. Brain Res. 494:1989;285-293.
26. Snyder E. Y. Grafting immortalized neurons to the CNS. Curr. Opin. Neurobiol. 4:1994;742-751.
27. Snyder G. L., Zigmond M. J. The effect of L-DOPA on in vivo dopamine release from striatum. Brain Res. 508:1990;181-187.
28. Steece-Collier K., Collier T. J., Sladek C. D., Sladek J. R. Jr. Chronic levodopa impairs morphological development of grafted embryonic dopamine neurons. Expl Neurol. 110:1990;201-208.
29. Tornatore C., Baker-Cairns B., Yadid G., Hamilton R., Meyers K., Atwood W., Cummins A., Tanner V., Major E. Expression of tyrosine hydroxylase in an immortalized human fetal astrocyte cell line; In vitro characterization and engraftment into the rodent striatum. Cell Transplant. 5(2):1996;145-163.
30. Tsukada H., Lindner K. J., Hartvig P., Langstrom B. Effect of 6R-L-erythro-5,6,7,8-tetrahydrobiopterin on the extracellular levels of dopamine and serotonin in the rat striatum: a microdialysis study with tyrosine or tryptophan infusion. Brain Res. 635:1994;59-67.
31. Uchida K., Tsuzaki N., Nagatsu T., Kohsaka S. Tetrahydrobiopterin-dependent functional recovery in 6-hydroxydopamine-treated rats by intracerebral grafting of fibroblasts transfected with tyrosine hydroxylase cDNA. Devl Neurosci. 14:1992;173-180.
32. Wang Y., Lin J. C., Chiou A. L., Liu J. Y., Liu J. C., Zhou F. C. Human ventromesencephalic grafts restore dopamine release and clearance in hemiparkinsonian rats. Expl Neurol. 136:1995;98-106.
33. Wasserstein P. H., Honig L. S. Parkinsonism during cyclosporine treatment. Bone Marrow Transplant. 18(3):1996;649-650.
34. Yadid G., Pacak K., Kopin I. J., Goldstein D. S. Modified microdialysis probe for sampling extracellular fluid and administering drugs in vivo. Am. J. Physiol. 265:1993;R1205-R1211.
35. Yadid G., Pacak K., Kopin I. J., Goldstein D. S. Endogenous serotonin stimulates striatal dopamine release in conscious rats. J. Pharmac. exp. Ther. 270:1994;1158-1165.